Vanguard Global Advisers
CNMD icon

Vanguard Global Advisers’s CONMED CNMD Stock Holding History

Vanguard Global Advisers’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
54,541
+9,583
+21% +$345K ﹤0.01% 1336
2026
Q1 		$1.59M Buy
+44,958
New +$1.83M ﹤0.01% 1350

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Vanguard Global Advisers's CNMD Position: Q2 2026 in Review

Vanguard Global Advisers increased its CONMED (CNMD) stake by 21% in Q2 2026, buying an estimated $345K and bringing the position to 54,541 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Vanguard Global Advisers first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Vanguard Global Advisers held 54,541 shares of CONMED worth $1.79M as of Q2 2026.
  • Vanguard Global Advisers bought 9,583 CONMED shares in Q2 2026, an estimated $345K.
  • CONMED made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1336 holding.
  • Vanguard Global Advisers first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.